METHOD FOR PRODUCING ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, AND METHOD FOR PRODUCING ELECTRONIC DEVICE

    公开(公告)号:EP3992179A1

    公开(公告)日:2022-05-04

    申请号:EP20833569.5

    申请日:2020-04-28

    摘要: An object of the present invention is to provide a method for producing an actinic ray-sensitive or radiation-sensitive resin composition that is capable of forming a pattern having suppressed defects. In addition, another object of the present invention is to provide a pattern forming method including the method for producing an actinic ray-sensitive or radiation-sensitive resin composition, and a method for manufacturing an electronic device, using the pattern forming method.
    The method for producing an actinic ray-sensitive or radiation-sensitive resin composition of an embodiment of the present invention is a method for producing an actinic ray-sensitive or radiation-sensitive resin composition including at least a resin having a polarity that increases due to decomposition by the action of an acid, a compound that generates an acid upon irradiation with actinic rays or radiation, and a solvent, in which the compound that generates an acid upon irradiation with actinic rays or radiation includes one or more compounds selected from the group consisting of a compound (I) to (III) below, and the actinic ray-sensitive or radiation-sensitive resin composition is produced by mixing a first solution including the resin having a polarity that increases by the action of an acid and a first solvent with the one or more compounds selected from the group consisting of the compound (I) to (III).

    A PHARMACEUTICAL COMPOSITION COMPRISING A SULFATED DERIVATIVE OF 3,5-DIIODO-O-[3-IODOPHENYL]-L-TYROSINE
    5.
    发明公开
    A PHARMACEUTICAL COMPOSITION COMPRISING A SULFATED DERIVATIVE OF 3,5-DIIODO-O-[3-IODOPHENYL]-L-TYROSINE 审中-公开
    含有3,5-二碘-O- [3-碘代苯基] -L-酪氨酸的硫酸化衍生物的药物组合物

    公开(公告)号:EP3260443A1

    公开(公告)日:2017-12-27

    申请号:EP17182061.6

    申请日:2012-04-05

    摘要: The present invention relates to a process for the preparation of the mono sodium salt of the derivative 3,5-diiodo-O-[3-iodo-4-(sulphooxy)phenyl]-L-tyrosine (T3S) by starting from the corresponding phenolic compound, in the presence of chlorosulfonic acid and dimethylacetamide as a solvent. The so obtained T3S compound may conveniently be isolated in a pure form as a solid in good yields.
    The present invention further relates to the process for T3S preparation, wherein the starting reagent is T2 and further comprising the formulation of such compound in tablets.
    Furthermore, the invention discloses non-radioactive immunoassays based on T3S derivatives.

    摘要翻译: 本发明涉及制备衍生物3,5-二碘-O- [3-碘-4-(磺酰氧基)苯基] -L-酪氨酸(T3S)的单钠盐的方法,从相应的 酚类化合物,在氯磺酸和二甲基乙酰胺作为溶剂存在下进行。 如此获得的T3S化合物可以方便地以良好收率以固体形式作为固体分离。 本发明进一步涉及用于T3S制备的方法,其中起始剂是T2并且还包含片剂中的这种化合物的制剂。 此外,本发明公开了基于T3S衍生物的非放射性免疫测定。

    QUATERNARY AMMONIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, THERAPEUTIC AGENT FOR CEREBROVASCULAR DISORDER, AND THERAPEUTIC AGENT FOR HEART DISEASE
    7.
    发明公开
    QUATERNARY AMMONIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, THERAPEUTIC AGENT FOR CEREBROVASCULAR DISORDER, AND THERAPEUTIC AGENT FOR HEART DISEASE 审中-公开
    季铵化合物; 方法进行生产,治疗剂AGAINST脑血管疾病和治疗剂预防心脏病

    公开(公告)号:EP1736464A1

    公开(公告)日:2006-12-27

    申请号:EP05727867.3

    申请日:2005-03-29

    摘要: A quaternary ammonium compound of the present invention is a quaternary ammonium compound represented by general formula (I) or (I')

    (wherein, A represents a linear alkyl group having 1 to 4 carbon atoms, a branched alkyl group having 2 to 4 carbon atoms, a linear alkyl group having 1 to 4 carbon atoms and a hydroxyl group, or a branched alkyl group having 2 to 4 carbon atoms and a hydroxyl group, R 1 to R 3 may be the same or different and represent a linear or branched alkyl group having 1 to 12 carbon atoms, one of R 4 to R 8 represents CO 2 - or SO 3 - , while no more than three of the remaining R 4 to R 8 represent a group selected from the group consisting of a hydroxyl group and an alkoxy group having 1 to 4 carbon atoms, and other R 4 to R 8 represent a hydrogen atom, one of R' 4 to R' 8 represents CO 2 H or SO 3 H, no more than three of the remaining R' 4 to R' 8 represent a group selected from a protected hydroxyl group and an alkoxy group having 1 to 4 carbon atoms, while other R' 4 to R' 8 represent a hydrogen atom, and X - represents an anion capable of forming a salt with a quaternary ammonium group).

    摘要翻译: 本发明的季铵化合物为季铵化合物由通式(I)或(I“)表示(worin,A darstellt具有1至4个碳原子,具有2至4个碳的支链烷基的直链烷基 原子,具有1至4个碳原子和羟基,或具有2-4个碳原子和羟基基团,R 1至R 3的支链状烷基的直链烷基可以是相同或不同,表示直链或支链的 烷基具有1至12个碳原子,R 4中的一个至R 8 darstellt CO 2 - 或SO 3 - ,而不超过三个其余的R 4至R 8表示选自以下的基团选自羟基的 并且在具有1至4个碳原子的烷氧基,和其它的R 4至R 8表示氢原子,不超过三个剩余的R的R“4至R” 8 darstellt CO 2 H或SO 3 H,其中一个“ 4至R“8表示从被保护的羟基基团和具有1至4个碳原子的烷氧基中的基团,而OT 前R“4至R” 8表示氢原子,X - darstellt阴离子的能够形成季铵基盐的)。